Bart De Leeuw

About

Bart De Leeuw joined Fund+ in 2023 as Partner & CFO. Prior to Fund+, he served as CFO and Risk Officer at Fortino Capital Partners and as Group Controller and Investment Manager at Ackermans & van Haaren. Earlier in his career, he spent over a decade at Ernst & Young, where he led the Technical Desk and was part of the EY global IFRS expert group in London. Bart holds a Master’s degree in Commercial Sciences and a Master’s degree in Business Information Systems from University of Brussels. He serves on the boards of Coave Therapeutics, EPICS Therapeutics, EyeD Pharmaceuticals, Minoryx Therapeutics and Novadip Biosciences.

Source (opens in a new tab)